Quantbot Technologies LP Has $2.56 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quantbot Technologies LP boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 121.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 77,250 shares of the medical instruments supplier’s stock after buying an additional 42,342 shares during the period. Quantbot Technologies LP’s holdings in DENTSPLY SIRONA were worth $2,564,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. Envestnet Portfolio Solutions Inc. raised its holdings in shares of DENTSPLY SIRONA by 6.6% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier’s stock valued at $357,000 after purchasing an additional 662 shares during the last quarter. Duality Advisers LP acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at approximately $1,166,000. John G Ullman & Associates Inc. raised its holdings in shares of DENTSPLY SIRONA by 31.7% in the first quarter. John G Ullman & Associates Inc. now owns 170,845 shares of the medical instruments supplier’s stock valued at $5,670,000 after purchasing an additional 41,115 shares during the last quarter. Texas Permanent School Fund Corp raised its holdings in shares of DENTSPLY SIRONA by 4.4% in the first quarter. Texas Permanent School Fund Corp now owns 43,793 shares of the medical instruments supplier’s stock valued at $1,453,000 after purchasing an additional 1,863 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at approximately $655,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded down $0.18 during trading on Friday, reaching $25.53. The company’s stock had a trading volume of 2,241,892 shares, compared to its average volume of 2,633,604. The business’s 50-day moving average price is $26.66 and its 200-day moving average price is $31.06. DENTSPLY SIRONA Inc. has a 52 week low of $23.94 and a 52 week high of $41.65. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.39 earnings per share. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date was Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on XRAY shares. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Needham & Company LLC decreased their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday. Finally, The Goldman Sachs Group reduced their price objective on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a research report on Monday, May 6th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $34.33.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of the stock in a transaction on Friday, May 31st. The stock was purchased at an average price of $27.95 per share, with a total value of $99,977.15. Following the completion of the purchase, the director now owns 58,374 shares in the company, valued at $1,631,553.30. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.52% of the stock is owned by insiders.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.